Availability and affordability of new medicines in Latin American countries where pivotal clinical trials were conducted | Zendy

Núria Homedes | Zendy; Antonio Ugalde | Zendy

Open Access

Availability and affordability of new medicines in Latin American countries where pivotal clinical trials were conducted

Author(s) -

Núria Homedes,

Antonio Ugalde

Publication year - 2015

Publication title -

bulletin of the world health organization

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.459

H-Index - 168

eISSN - 1564-0604

pISSN - 0042-9686

DOI - 10.2471/blt.14.151290

Subject(s) - latin americans , clinical trial , pharmacy , population , developing country , medicine , business , developed country , food and drug administration , environmental health , family medicine , economic growth , economics , political science , pathology , law

To assess whether new pharmaceutical products approved by the United States Food and Drug Administration (FDA) in 2011 and 2012 were registered, commercialized and sold at affordable prices in the Latin American countries where they were tested.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research